Results

Total Results: 2,078 records

Showing results for "drugs".

  1. effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_1.pdf
    April 01, 2020 - Finally, although only a few prescription drugs are approved by the U.S. … – There was minimal evidence addressing whether efficacy of prescription drugs for CATD treatment … (n=454), and five that compared prescription drugs with supplements (n=258). … Two trials compared different prescription drugs (n=414). … Evidence on the efficacy and harms of CATD drugs had several limitations.
  2. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - San Diego (CA): Arena Pharmaceuticals, Inc; 2010 Nov 9 [accessed 2011 Dec 16]. [3 p]. … New data from Arena Pharmaceuticals' pivotal BLOSSOM trial of lorcaserin demonstrate improvements … Washington (DC): Arena Pharmaceuticals, Inc.; 2009 Oct 27 [accessed 2011 Apr 21]. [4 p]. … San Diego (CA): Arena Pharmaceuticals; 2012 Jun 27 [accessed 2012 Jul 5]. [4 p]. … Arena Pharmaceuticals. Lorcaserin hydrochloride. Drugs Future. 2007;32(9):766-70. 78.
  3. effectivehealthcare.ahrq.gov/products/osteoporosis-bone-fracture/research-protocol
    May 14, 2010 - Controlled clinical trials that report fracture outcomes for one or more of the drugs of interest will … Articles of any study design that report on adherence/persistence for any of the drugs of interest will … In our search to identify clinical studies of drugs of interest to this review, we will use terms for … osteoporosis, osteopenia, low bone density, and the drugs listed in the key questions (as well as any … In our search for the key AE, we will use terms for the AE and each of the drugs of interest for this
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-cardiovascular-elderly_research.pdf
    February 01, 2009 - .10 Another observational study found higher mortality in those given haloperidol vs. two atypical drugs … FDA warns antipsychotic drugs may be risky for elderly. JAMA 2005;293:2462. 3. Strong C. … Using antipsychotic agents in older patients: expert consensus panel for using antipsychotic drugs … Antipsychotic drugs: prolonged QTc Interval, Torsade de Pointes, and sudden death. … Antipsychotic drugs in dementia: what should be made of the risks? JAMA 2005;294:1963-1965.
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_executive.pdf
    April 01, 2012 - The absolute risk difference in continence was less than 20 percent for all drugs. … Adverse effects were common with all drugs and varied between the drugs. … Treatment discontinuation due to adverse effects of drugs is common. … Benefits and harms with drugs did not differ by individual quality criteria. … • Drugs for urgency UI demonstrated similar effectiveness.
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/executive-summary-2017-schizophrenia-adult.pdf
    January 01, 2017 - and in 2013 for SGA versus SGA drugs. … in effects associated with individual drugs. … This analysis found that all of the drugs included were superior to placebo. … The newer drugs primarily have evidence only for symptom-based outcomes and adverse events. … • Ensure comparable dosing with the best dosing titration methods for all drugs included.
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
    January 01, 2013 - CER #51: Dietary Supplements in Adults Taking Cardiovascular Drugs Original release date: April … ................................ 5 1 Dietary Supplements in Adults Taking Cardiovascular Drugs … Comparative Effectiveness Review (CER) #51, Dietary Supplements in Adults Taking Cardiovascular Drugs … Dietary Supplements in Adults Taking Cardiovascular Drugs. … OR exp Phytotherapy/ or exp Plant Preparations/ or exp Plant Extracts/ or exp Drugs, Chinese Herbal/
  8. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … The topic, buprenorphine implant (Probuphine,™ Titan Pharmaceuticals, Inc., South San Francisco, CA
  9. S44 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s44.pdf
    October 01, 2007 - : DD trials deviated from ideal PRTs in the policymakers’ domain: the policies affected mixtures of drugs … The idea that PharmaCare should use a delayed control group to evaluate drugs and policy changes was … Duration of Delays Fortunately, the policy concerned respiratory drugs with short-term effects. … A 6-month trial would have been more problematic for drugs, such as statins, with cumulative effects … Medicare holds lottery for access to expensive drugs. Am J Health Syst Pharm. 2004;61:1632,1636.
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-seniors-death_research.pdf
    August 01, 2007 - mood disorders, psychotic disorders, and other psychiatric disorders), prior use of anticholinergic drugs … , and current co- medication with anticholinergic drugs. … Using antipsychotic agents in older patients: Expert Consensus Panel for Using Antipsychotic Drugs in … FDA warns antipsychotic drugs may be risky for elderly. JAMA. 2005; 293: 2462. 9 Strong C. … , current use of anticholinergic drugs, total number of medications used, hospitalization and nursing
  11. effectivehealthcare.ahrq.gov/products/migraine-prevention/overview
    June 03, 2013 - Archived June 3, 2013 This topic focuses on the comparative effectiveness and safety of the drugs
  12. effectivehealthcare.ahrq.gov/products/tinnitus/research
    August 23, 2013 - pharmacological interventions, SOE is low for improvements to subjective loudness from neurotransmitter drugs … versus placebo; insufficient for antidepressants, other drugs, and food supplements with respect to
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-evidence-summary-corticosteroids-asthma.pdf
    October 01, 2017 - long-term maintenance treatment of asthma in patients 6 years and older.4 The review focuses on drugsDrugs included in the review Class Drugs ICS Beclomethasone,a budesonide,a ciclesonide,a Flunisolide … Drugs 2009;69:137-150. PMID: 19228072. 4. Spiriva Respimat [package insert]. … Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT. 2016.
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_surveillance.pdf
    October 29, 2012 - How do combined modalities of nonpharmacological treatments with drugs affect incontinence, UI severity … * p<0.05; **p<0.001; ***p<0.01 No Signal Anticholinergic drugs vs. onabotulinumtoxinA … The absolute risk difference in continence was less than 20 percent for all drugs. … The absolute risk difference in continence was less than 20 percent for all drugs. … The numbers needed to treat (NNT) to achieve continence in one woman were similar across drugs.
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine_protocol-appendix_20111103.pdf
    November 03, 2011 - ANTI-DEMENTIA Donepezil, N06DA02 N06 PSYCHOANALEPTICS Memantine, N06DX01 N06D ANTI-DEMENTIA DRUGS … Montelukast, R03DC03 R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES R03DC Leukotriene … Ariston Pharmaceuticals, Inc. … Elan Pharmaceuticals Eli Lilly and Company Endo Pharmaceuticals EUROHEAD GlaxoSmithKline HaEmek … King Pharmaceuticals Lotus Pharmaceutical MAP Pharmaceuticals, Inc.
  16. effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … The search is on for ways to definitively diagnose AD and for drugs, biologics, and alternative or … Peripheral and Central Nervous System Drugs Advisory Committee.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_executive.pdf
    July 01, 2014 - benzodiazepines), and drugs for insomnia? … Interventions Interventions include commonly used antidepressant drugs listed in Table A. … • The drugs in Table A compared with each other • Any nonpharmacological treatment. … searches (3,405 citations), manual searches (53 citations), and scientific information packets (Forest Pharmaceuticals … , Inc.; Jazz Pharmaceuticals; and Sanofi Aventis, U.S.), we identified a total of 3,458 potentially
  18. effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
    September 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For emerging pharmaceuticals or biotechnologies 23 that have not yet reached market and lack cost … information, we used as proxies novel pharmaceuticals or biotechnologies entering the market within … Covers future industry trends, key industry developments, research and development of drugs and pharmaceuticals … Industries covered: pharmaceuticals, biotechnology, medical equipment & devices, and in vitro diagnostics
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
    September 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For emerging pharmaceuticals or biotechnologies 23 that have not yet reached market and lack cost … information, we used as proxies novel pharmaceuticals or biotechnologies entering the market within … Covers future industry trends, key industry developments, research and development of drugs and pharmaceuticals … Industries covered: pharmaceuticals, biotechnology, medical equipment & devices, and in vitro diagnostics
  20. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
    January 01, 2012 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Teduglutide (Gattex®, NPS Pharmaceuticals, Bedminster, NJ) is a subcutaneously administered glucagon-like … Teduglutide (Gattex®, NPS Pharmaceuticals, Bedminster, NJ) is intended to provide several critical … NPS Pharmaceuticals; 2011 May 12 [accessed 2011 Jul 15]. [2 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 Oct 31 [accessed 2011 Nov 11]. [4 p].

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: